
Spastra MF 250mg/325mg Tablet
Marketer
Mestra Pharma Pvt Ltd
Salt Composition
Mefenamic Acid (250mg) + Paracetamol (325mg)
Overview Spastra MF 250mg/325mg Tablet
Combiflex 250mg/325mg tablets contain a dual-action formula for fever reduction. This medication also effectively manages mild to moderate pain associated with headaches, muscle aches, and dental pain. Always take Combiflex with food to minimize stomach upset. Dosage is determined by your condition and response to treatment; follow your physician's instructions precisely. Avoid exceeding the recommended dose or duration. Common side effects may include nausea, vomiting, diarrhea, indigestion, appetite loss, and heartburn. Report any persistent or worsening side effects to your doctor, who can offer strategies for management. Prior to use, inform your doctor of any pre-existing stomach ulcers or bleeding, hypertension, or conditions affecting your heart, kidneys, or liver. Always disclose all other medications you are currently using, as interactions are possible.
Primary Ingredients of Spastra MF 250mg/325mg Tablet
There is no text provided to rephrase.
Uses of Spastra MF 250mg/325mg Tablet
Alleviating pain and reducing fever.
Major Benefits of Spastra MF 250mg/325mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Spastra MF 250mg/325mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Spastra MF 250mg/325mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Indigestion
- Loss of appetite
- Heartburn
How to use Spastra MF 250mg/325mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Spastra MF 250mg/325mg tablet whole; do not break, crush, or chew it. Administer this medication with food.
How Spastra MF 250mg/325mg Tablet works:
Each Spastra MF 250mg/325mg tablet combines mefenamic acid and paracetamol to alleviate fever, pain, and inflammation. This dual-action formulation inhibits the production of inflammatory mediators responsible for these symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Spastra MF 250mg/325mg tablets is hazardous.
PregnancyCONSULT YOUR DOCTOR
Use of Spastra MF 250mg/325mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Spastra MF 250mg/325mg tablets during lactation is considered safe. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Spastra MF 250mg/325mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Spastra MF 250mg/325mg Tablets, as dose modification may be necessary. Medical advice is recommended. Spastra MF 250mg/325mg Tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Spastra MF 250mg/325mg tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Spastra MF 250mg/325mg tablets are contraindicated in individuals with severe or active liver disease.
What if you forget to take Spastra MF 250mg/325mg Tablet :
Should you forget to take your Spastra MF 250mg/325mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spastra MF 250mg/325mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
